Awardee OrganizationOREGON HEALTH & SCIENCE UNIVERSITY
Description
Abstract Text
DESCRIPTION (provided by applicant): A quantitative trait locus (QTL) is a site on a chromosome containing genes (alleles) influencing a quantitative or multilocus trait. In our present RO1 grant, QTL analysis was used to detect and map ten QTLs influencing either acute or chronic alcohol (EtOH) withdrawal severity to broad chromosomal regions using crosses between the C57BL/6 (B6) x DBA/2 (D2) and the Withdrawal Seizure Prone (IP2) x Withdrawal Seizure Resistant (IR1) inbred strains. The gene has been identified which accounts for one of these, and good progress toward this end has been made for another. In this proposal we plan to advance toward gene identification for the seven QTLs focused on the chronic alcohol withdrawal model in B6xD2 and IP2xlR1 crosses rather than the acute model used in the past. The approach is to combine gene expression microarray and QTL data taken in the same mice to take full advantage of the complementary strengths and weaknesses of these two genome-wide methods of gene discovery. Recent work has shown that individual variation in gene expression in brain for most genes, as indexed by transcript (mRNA) abundance, is often controlled by multiple loci (QTLs). By combining microarray and QTL (quantitative trait locus) analysis on the same mice, we propose to detect those transcripts most likely to have a direct influence oh withdrawal severity by determining which transcripts segregate with withdrawal variation and which do not, and also which QTLs jointly influence variation in transcript abundance for particular gene(s) and withdrawal severity. We will use short-term selected lines bred for high and low chronic alcohol withdrawal severity to verify differential gene expression for candidate genes cosegregating with withdrawal severity. Analyses of specialized high resolution mapping populations of congenic strains, haplotype analyses, and analyses of gene function will provide increasing differentiation among candidate genes which will contribute importantly toward the identification of those genes responsible for the seven known QTLs influencing chronic alcohol withdrawal severity. Another major focus of these studies is to determine the effects of chronic intoxication, either with or without withdrawal, on gene regulation throughout the genome, as this will provide important clues concerning mechanism. We will use the newly available Affymetrix mouse 430 2.0 Genechip(r) representing the vast majority of all genes in the mouse genome.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AccountingAcuteAffectAirAlcohol Withdrawal SeizuresAlcohol withdrawal syndromeAlcoholic IntoxicationAlcoholsAldehydesAllelesAnalysis of VarianceAppendixBrainBreathingBreedingButanolsCandidate Disease GeneCatalogingCatalogsChromosomesChromosomes, Human, Pair 1ChronicClinicalCommunitiesConditionCongenic MiceCongenic StrainConsumptionControl GroupsConvulsionsCore FacilityCouplingDataDatabasesDetectionDevelopmentDiazepamDisease modelDissectionDistalDrug abuseEthanolExcisionFacultyFosteringFrequenciesFundingFutureGene ExpressionGene Expression Microarray AnalysisGene Expression RegulationGene FrequencyGenerationsGenesGeneticGenetic PolymorphismGenetic Predisposition to DiseaseGenetic VariationGenomeGenotypeGoalsGrantHaplotypesHourHypnotics and SedativesIn Situ HybridizationInbred StrainIndividualInstitutesIntoxicationJointsLaboratoriesLeadLinkLocationMapsMeasuresMembrane Structure and FunctionMessenger RNAMethodsMicroarray AnalysisMicrosatellite RepeatsModelingMonitorMusNational Institute on Alcohol Abuse and AlcoholismNatureNeuro-Oncological Ventral Antigen 2Nitrous OxideNumbersPathway interactionsPentobarbitalPersonal SatisfactionPharmaceutical PreparationsPhenotypePhysical DependencePopulationPositioning AttributePredispositionProblem SolvingProcessProcess MeasureProgress ReportsProteinsPurposeQTL GenesQuantitative Trait LociRegulationRelapseRelative (related person)ReportingResearchResistanceResolutionReverse Transcriptase Polymerase Chain ReactionRodent ModelRoleRunningSamplingScoreSeizuresSequence AnalysisSeveritiesSiteSorting - Cell MovementSourceStandards of Weights and MeasuresStatistically SignificantStudy SubjectSubstance Withdrawal SyndromeSynaptic MembranesTertiary Protein StructureTestingThinkingTimeTissue-Specific Gene ExpressionTissuesTranscriptTransgenic MiceTranslatingUnited States National Institutes of HealthVariantWestern BlottingWithdrawalWorkalcohol and other drugalcohol exposurebasebrain tissuechronic alcohol ingestionclinically relevantcomparativecomparison groupcongeniccostdaydesigndrinkingdrug withdrawalfollow-upgene discoverygene functiongenetic analysisindexinginterestkillingsmouse genomeneurochemistryneurophysiologynew technologypreferenceproblem drinkerpromoterprotein functionresearch studysuccesstraittrendunpublished worksvapor
National Institute on Alcohol Abuse and Alcoholism
CFDA Code
273
DUNS Number
096997515
UEI
NPSNT86JKN51
Project Start Date
01-September-1988
Project End Date
31-July-2009
Budget Start Date
01-August-2007
Budget End Date
31-July-2008
Project Funding Information for 2007
Total Funding
$268,810
Direct Costs
$213,341
Indirect Costs
$55,469
Year
Funding IC
FY Total Cost by IC
2007
National Institute on Alcohol Abuse and Alcoholism
$268,810
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AA006243-22
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AA006243-22
Patents
No Patents information available for 5R01AA006243-22
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AA006243-22
Clinical Studies
No Clinical Studies information available for 5R01AA006243-22
News and More
Related News Releases
No news release information available for 5R01AA006243-22
History
No Historical information available for 5R01AA006243-22
Similar Projects
No Similar Projects information available for 5R01AA006243-22